Stanback
- Product NDC
- 63029-501
- 11-digit product format
- 630290501
- Labeler code
- 63029
- Product ID
- 63029-501_c7af9f6c-018c-4612-b0a6-ba2e90fbec37
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Aspirin and Caffeine
- Dosage form
- POWDER
- Route
- ORAL
- Labeler
- Medtech Products Inc.
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2012-10-01
- Substance
- CAFFEINE; ASPIRIN
- Active strength
- 65; 845 mg/1; mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 63029-501 | 63029-501-24 | D | Discontinued by firm | 2026-10-15 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | ed331223b511… | 672a5bd82f5f… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Stanback
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| CAFFEINE | 65 mg/1 |
| ASPIRIN | 845 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 3G6A5W338E | Internal UNII lookup |
| R16CO5Y76E | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| caaa1313-09e4-45aa-8836-346f6a370196 | Available on FDA.report |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 63029-501-01 | 2020-04-23 | Stanback |
| 63029-501-02 | 2020-04-23 | Stanback |
| 63029-501-06 | 2020-04-23 | Stanback |
| 63029-501-24 | 2020-04-23 | Stanback |
| 63029-501-01 | 2020-01-31 | Stanback |
| 63029-501-02 | 2020-01-31 | Stanback |
| 63029-501-06 | 2020-01-31 | Stanback |
| 63029-501-24 | 2020-01-31 | Stanback |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63029-501-01 | Stanback | 50 in 1 CARTON | POWDER | 50 | 12 | |
| 63029-501-02 | Stanback | 2 in 1 PACKAGE | POWDER | 2 | 12 | |
| 63029-501-06 | Stanback | 6 in 1 PACKAGE | POWDER | 6 | 12 | |
| 63029-501-24 | Stanback | 24 in 1 CARTON | POWDER | 24 | 12 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63029-501-01 | EA - Each | 63029-501 | 1a6a8f40-6b56-4858-b452-bcdc4963344a | 1 | 2022-06-06 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ASPIRIN | ACTIVE INGREDIENT | R16CO5Y76E | STANBACK (ASPIRIN AND CAFFEINE) POWDER [MEDTECH PRODUCTS INC.] | 1 | |
| CAFFEINE | ACTIVE INGREDIENT | 3G6A5W338E | STANBACK (ASPIRIN AND CAFFEINE) POWDER [MEDTECH PRODUCTS INC.] | 1 | |
| ASPIRIN | ACTIVE MOIETY | R16CO5Y76E | STANBACK (ASPIRIN AND CAFFEINE) POWDER [MEDTECH PRODUCTS INC.] | 1 | |
| CAFFEINE | ACTIVE MOIETY | 3G6A5W338E | STANBACK (ASPIRIN AND CAFFEINE) POWDER [MEDTECH PRODUCTS INC.] | 1 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | STANBACK (ASPIRIN AND CAFFEINE) POWDER [MEDTECH PRODUCTS INC.] | 1 | |
| FUMARIC ACID | INACTIVE INGREDIENT | 88XHZ13131 | STANBACK (ASPIRIN AND CAFFEINE) POWDER [MEDTECH PRODUCTS INC.] | 1 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | STANBACK (ASPIRIN AND CAFFEINE) POWDER [MEDTECH PRODUCTS INC.] | 1 | |
| POTASSIUM CHLORIDE | INACTIVE INGREDIENT | 660YQ98I10 | STANBACK (ASPIRIN AND CAFFEINE) POWDER [MEDTECH PRODUCTS INC.] | 1 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Aspirin | ASPIRIN | United Natural Foods, Inc. dba UNFI | 19c7f832-d7ec-4dcc-8aa4-f4cbf64c9ff6 | 2026-07-02 | Warnings | M013 |
| pain relief EXTRA STRENGTH | ACETAMINOPHEN | Meijer Distribution, Inc. | ae84eb7e-a70b-4311-b2dc-ad153047a516 | 2026-07-01 | Warnings | M013 |
| Aspirin 325 mg | ASPIRIN | Hi-Tech Nutraceuticals, LLC | b3426a9a-ea99-da30-e053-2995a90a1e4b | 2026-07-01 | Warnings | M013 |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | Salado Sales, Inc. | ca21d576-be3c-495d-9dbd-ed514bf65da7 | 2026-07-01 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Meijer Distribution Inc | 4e08a7cb-3894-84c3-e063-6394a90a0b42 | 2026-06-30 | Warnings | M013 |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | Wal-Mart Stores Inc | 9b1201af-c802-4e19-b192-bbbf34367db4 | 2026-06-30 | Warnings | M013 |
| Pain Reliever | ACETAMINOPHEN | P & L Development, LLC | fc841cba-8f4f-407b-97de-0422977515bd | 2026-06-30 | Warnings | M013 |
| Headache Relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | United Natural Foods, Inc. dba UNFI | b6ff2b34-51ee-41bc-8b7d-7520ade0bf36 | 2026-06-30 | Warnings | M013 |
| Medline | ASPIRIN | Medline Industries, LP | 4b0c569a-ed7a-e104-e063-6394a90a6d54 | 2026-06-29 | Warnings | M013 |
| Pain Reliever PM | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | WALMART INC. | e50b3f60-b827-426c-8e78-8447c89130fe | 2026-06-29 | Warnings | M013 |
| Acetaminophen PM | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | Chain Drug Marketing Association, Inc. | e58417f4-3575-4433-ac2e-b7bf9fe8ba10 | 2026-06-29 | Warnings | M013 |
| Dr Kids Pain and Fever | ACETAMINOPHEN | CalmCo LLC | 5534a784-a7b1-5599-e063-6294a90a7961 | 2026-06-27 | Warnings | M013 |
| TYLENOL Extra Strength | ACETAMINOPHEN | Select Consumer Group LLC | 529d3a51-a248-7c02-e063-6294a90a10ae | 2026-06-27 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Sportpharm LLC | 830ffcaa-7ff8-4732-bc84-6a8c5e78722d | 2026-06-25 | Warnings | M013 |
| Aspirin | ASPIRIN | Strategic Sourcing Services LLC | ea2ef485-429e-4c63-ba7b-0a6b32892ad2 | 2026-06-25 | Warnings | M013 |
| Aspirin | ASPIRIN | Chain Drug Marketing Association, Inc. | 055d8420-c189-4a9e-acdc-21627935c8eb | 2026-06-25 | Warnings | M013 |
| Aspirin | ASPIRIN | Topco Associates, LLC | 5f32cf74-dbea-496c-ba23-2040ea354f40 | 2026-06-25 | Warnings | M013 |
| Aspirin | ASPIRIN | Salado Sales, Inc. | cf3139a5-e36e-48e3-bb6c-e102b0cec555 | 2026-06-25 | Warnings | M013 |
| Pain Relief Aspirin | ASPIRIN | Rite Aid Corporation | bd69d3d2-5d38-47c6-98a6-124f7a43b8b0 | 2026-06-25 | Warnings | M013 |
| Aspirin Regular Strength | ASPIRIN | Walgreen Company | 0b27c0fd-7ea8-4588-9169-5ad4e8df77ef | 2026-06-25 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 994435 | aspirin 845 MG / caffeine 65 MG Oral Powder | PSN | caaa1313-09e4-45aa-8836-346f6a370196 | 12 |
| 1053327 | STANBACK Headache Powder 845 MG / 65 MG Oral Powder, Reformulated Jan 2011 | PSN | caaa1313-09e4-45aa-8836-346f6a370196 | 12 |
| 1053327 | aspirin 845 MG / caffeine 65 MG Oral Powder [Stanback Headache Powder Reformulated Jan 2011] | SBD | caaa1313-09e4-45aa-8836-346f6a370196 | 12 |
| 994435 | aspirin 845 MG / caffeine 65 MG Oral Powder | SCD | caaa1313-09e4-45aa-8836-346f6a370196 | 12 |
| 994435 | ASA 845 MG / Caffeine 65 MG Oral Powder | SY | caaa1313-09e4-45aa-8836-346f6a370196 | 12 |
| 1053327 | ASA 845 MG / Caffeine 65 MG Oral Powder [Stanback Headache Powder Reformulated Jan 2011] | SY | caaa1313-09e4-45aa-8836-346f6a370196 | 12 |
| 1053327 | Stanback Headache Powder Reformulated Jan 2011 (ASA 845 MG / caffeine 65 MG) Oral Powder | SY | caaa1313-09e4-45aa-8836-346f6a370196 | 12 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 63029-501-01 | 63029050101 | 50 POWDER in 1 CARTON (63029-501-01) | 50 powder | 2012-10-01 | 0000-00-00 | No | No | Current |
| 63029-501-02 | 63029050102 | 2 POWDER in 1 PACKAGE (63029-501-02) | 2 powder | 2012-10-01 | 0000-00-00 | No | No | Current |
| 63029-501-06 | 63029050106 | 6 POWDER in 1 PACKAGE (63029-501-06) | 6 powder | 2012-10-01 | 0000-00-00 | No | No | Current |
| 63029-501-24 | 63029050124 | 24 POWDER in 1 CARTON (63029-501-24) | 24 powder | 2012-06-01 | 0000-00-00 | No | No | Current |